1[3]Duncan AC.Human herpesvirus 6.Rev Med Virol,2000,10:155-173
2[4]Yoshikawa T.Human herpesvirus-6 and-7 infections in transplantation.Pediatric Transplantation,2003,7:11-17
3[5]Clark DA,Griffiths PD.Human herpesvirus 6:relevance of infection in the immunocompromised host.Bri J Haemat,2003,120:384-390
4[6]Vincent C.Human herpesviruses 6 and 7 in solid organ transplant recipients.Clin Infect Dis,2001,32:1357-1360
5[7]Jacobson S.Association of chronic progressive neurological disease and ubiquitous viral agents:lessons from human herpesvirus 6and multiple sclerosis.Mol Psychiatry,2002,7:S29-S31
6[8]Yamanish IK,Okun OT,Shirak IK,et al.Identification of human herpesvirus 6 as a causal agent for exanthem subitum.The Lancet,1988,1:1065-1067
7[9]Takahashi K,Suzuki M,Wata Y,et al.Selective activity of various nucleoside and nucleotide analogues against herpesvirus 6 and 7.Antivir Chem Chemother,1997,8:24 -31
8[10]Griffiths PD.Tomorrow's challenges for herpesvirus management:potential applications of valaeyclovir.J Infect Dis,2002,186(Suppl 1):S131-S137
9[1]Hall CB,Caserta MT,Schnabel KC,et al.Persistence of human herpesvirus 6 according to site and variant:possible greater neurotropism of variant A.Clin Infect Dis,1998,26(1):132-137
10[2]Jay AL.Three new human herpesviruses (HHV-6,7,and 8).Lancet,1997,1349:558-563
